Sunshine Mills, Inc.

CLOSEOUT LETTER Sunshine Mills, Inc. MARCS-CMS 618141 — December 21, 2023 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Animal & Veterinary Recipient: Recipient Name Mr. Alan Bostick Recipient Title CEO Sunshine Mills, Inc. PO Box 676 Red Bay , AL 35582 United States Issuing Office: Human and Animal Food East V Compliance Branch (HAFE5-CB) United States Secondary Issuing Offices United States Dear Mr. Bostick: The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter #618141, dated March 7, 2022. Based on our evaluation, it appears that you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Allison C. Hunter Compliance Officer Content current as of: 02/02/2024 Regulated Product(s) Animal & Veterinary